Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lieke H. Meeter"'
Autor:
Lucia A. A. Giannini, Ruben G. Boers, Emma L. van derEnde, Jackie M. Poos, Lize C. Jiskoot, Joachim B. Boers, Wilfred F. J. vanIJcken, Elise G. Dopper, Yolande A. L. Pijnenburg, Harro Seelaar, Lieke H. Meeter, Jeroen G. J. vanRooij, Wiep Scheper, Joost Gribnau, John C. vanSwieten
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 11, Iss 3, Pp 744-756 (2024)
Abstract Objective Methylation of plasma cell‐free DNA (cfDNA) has potential as a marker of brain damage in neurodegenerative diseases such as frontotemporal dementia (FTD). Here, we study methylation of cfDNA in presymptomatic and symptomatic carr
Externí odkaz:
https://doaj.org/article/cc79cf26f61340c983c838b9a38da340
Autor:
Emma L. van der Ende, Carolin Heller, Aitana Sogorb-Esteve, Imogen J. Swift, David McFall, Georgia Peakman, Arabella Bouzigues, Jackie M. Poos, Lize C. Jiskoot, Jessica L. Panman, Janne M. Papma, Lieke H. Meeter, Elise G. P. Dopper, Martina Bocchetta, Emily Todd, David Cash, Caroline Graff, Matthis Synofzik, Fermin Moreno, Elizabeth Finger, Raquel Sanchez-Valle, Rik Vandenberghe, Robert Laforce, Mario Masellis, Maria Carmela Tartaglia, James B. Rowe, Chris Butler, Simon Ducharme, Alexander Gerhard, Adrian Danek, Johannes Levin, Yolande A. L. Pijnenburg, Markus Otto, Barbara Borroni, Fabrizio Tagliavini, Alexandre de Mendonça, Isabel Santana, Daniela Galimberti, Sandro Sorbi, Henrik Zetterberg, Eric Huang, John C. van Swieten, Jonathan D. Rohrer, Harro Seelaar, the Genetic Frontotemporal Dementia Initiative (GENFI)
Publikováno v:
Journal of Neuroinflammation, Vol 19, Iss 1, Pp 1-13 (2022)
Abstract Background Neuroinflammation is emerging as an important pathological process in frontotemporal dementia (FTD), but biomarkers are lacking. We aimed to determine the value of complement proteins, which are key components of innate immunity,
Externí odkaz:
https://doaj.org/article/319fc84ce3124ac6ae190548e67faa37
Autor:
Oskar Hansson, Alexander F. Santillo, Lieke H. Meeter, Karin Nilsson, Maria Landqvist Waldö, Christer Nilsson, Kaj Blennow, John C. vanSwieten, Shorena Janelidze
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 6, Iss 5, Pp 863-872 (2019)
Abstract Objective Diagnosis of frontotemporal dementia (FTD) is complicated by the overlap of clinical symptoms with other dementia disorders. Development of robust fluid biomarkers is critical to improve the diagnostic work‐up of FTD. Methods CSF
Externí odkaz:
https://doaj.org/article/0a4da932aae14219ad3699c9bc143835
Autor:
Lize C. Jiskoot, Martina Bocchetta, Jennifer M. Nicholas, David M. Cash, David Thomas, Marc Modat, Sebastien Ourselin, Serge A.R.B. Rombouts, Elise G.P. Dopper, Lieke H. Meeter, Jessica L. Panman, Rick vanMinkelen, Emma L. van derEnde, Laura Donker Kaat, Yolande A.L. Pijnenburg, Barbara Borroni, Daniela Galimberti, Mario Masellis, Maria Carmela Tartaglia, James Rowe, Caroline Graff, Fabrizio Tagliavini, Giovanni B. Frisoni, Robert Laforce Jr, Elizabeth Finger, Alexandre deMendonça, Sandro Sorbi, on behalf of the Genetic Frontotemporal dementia Initiative (GENFI), Janne M. Papma, John C. vanSwieten, Jonathan D. Rohrer
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 5, Iss 9, Pp 1025-1036 (2018)
Abstract Objective We aimed to investigate mutation‐specific white matter (WM) integrity changes in presymptomatic and symptomatic mutation carriers of the C9orf72, MAPT, and GRN mutations by use of diffusion‐weighted imaging within the Genetic F
Externí odkaz:
https://doaj.org/article/5ea32abf654c46c99d65c871dd01a86f
Autor:
Marta del Campo, Yolande A. L. Pijnenburg, Alice Chen-Plotkin, David J. Irwin, Murray Grossman, Harry A. M. Twaalfhoven, William T. Hu, Lieke H. Meeter, John van Swieten, Lisa Vermunt, Frans Martens, Annemieke C. Heijboer, Charlotte E. Teunissen
Publikováno v:
Biomolecules, Vol 11, Iss 10, p 1484 (2021)
Biomarkers to discriminate the main pathologies underlying frontotemporal lobar degeneration (FTLD-Tau, FTLD-TDP) are lacking. Our previous FTLD cerebrospinal fluid (CSF) proteome study revealed that sex hormone-binding globulin (SHBG) was specifical
Externí odkaz:
https://doaj.org/article/96cf6d2713854392aa07dd9c128bf6b1
Autor:
Marta del Campo, Carel F. W. Peeters, Erik C. B. Johnson, Lisa Vermunt, Yanaika S. Hok-A-Hin, Mirrelijn van Nee, Alice Chen-Plotkin, David J. Irwin, William T. Hu, James J. Lah, Nicholas T. Seyfried, Eric B. Dammer, Gonzalo Herradon, Lieke H. Meeter, John van Swieten, Daniel Alcolea, Alberto Lleó, Allan I. Levey, Afina W. Lemstra, Yolande A. L. Pijnenburg, Pieter J. Visser, Betty M. Tijms, Wiesje M. van der Flier, Charlotte E. Teunissen
Publikováno v:
Nature aging, 2(11), 1040-+. Nature Publishing Group
del Campo, M, Peeters, C F W, Johnson, E C B, Vermunt, L, Hok-A-Hin, Y S, van Nee, M, Chen-Plotkin, A, Irwin, D J, Hu, W T, Lah, J J, Seyfried, N T, Dammer, E B, Herradon, G, Meeter, L H, van Swieten, J, Alcolea, D, Lleó, A, Levey, A I, Lemstra, A W, Pijnenburg, Y A L, Visser, P J, Tijms, B M, van der Flier, W M & Teunissen, C E 2022, ' CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels ', Nature Aging, vol. 2, no. 11, pp. 1040-1053 . https://doi.org/10.1038/s43587-022-00300-1
Nature Aging, 2(11), 1040-1053
Nature Aging, 2(11), 1040-1053. Springer
Nature Aging 2 (2022) 11
del Campo, M, Peeters, C F W, Johnson, E C B, Vermunt, L, Hok-A-Hin, Y S, van Nee, M, Chen-Plotkin, A, Irwin, D J, Hu, W T, Lah, J J, Seyfried, N T, Dammer, E B, Herradon, G, Meeter, L H, van Swieten, J, Alcolea, D, Lleó, A, Levey, A I, Lemstra, A W, Pijnenburg, Y A L, Visser, P J, Tijms, B M, van der Flier, W M & Teunissen, C E 2022, ' CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels ', Nature Aging, vol. 2, no. 11, pp. 1040-1053 . https://doi.org/10.1038/s43587-022-00300-1
Nature Aging, 2(11), 1040-1053
Nature Aging, 2(11), 1040-1053. Springer
Nature Aging 2 (2022) 11
Development of disease-modifying therapies against Alzheimer's disease (AD) requires biomarkers reflecting the diverse pathological pathways specific for AD. We measured 665 proteins in 797 cerebrospinal fluid (CSF) samples from patients with mild co
Autor:
Emma L van der Ende, Lieke H Meeter, Jackie M Poos, Jessica L Panman, Lize C Jiskoot, Elise G P Dopper, Janne M Papma, Frank Jan de Jong, Inge M W Verberk, Charlotte Teunissen, Dimitris Rizopoulos, Carolin Heller, Rhian S Convery, Katrina M Moore, Martina Bocchetta, Mollie Neason, David M Cash, Barbara Borroni, Daniela Galimberti, Raquel Sanchez-Valle, Robert Laforce, Fermin Moreno, Matthis Synofzik, Caroline Graff, Mario Masellis, Maria Carmela Tartaglia, James B Rowe, Rik Vandenberghe, Elizabeth Finger, Fabrizio Tagliavini, Alexandre de Mendonça, Isabel Santana, Chris Butler, Simon Ducharme, Alex Gerhard, Adrian Danek, Johannes Levin, Markus Otto, Giovanni B Frisoni, Stefano Cappa, Yolande A L Pijnenburg, Jonathan D Rohrer, John C van Swieten, Martin N. Rossor, Jason D. Warren, Nick C. Fox, Ione O.C. Woollacott, Rachelle Shafei, Caroline Greaves, Rita Guerreiro, Jose Bras, David L. Thomas, Jennifer Nicholas, Simon Mead, Rick van Minkelen, Myriam Barandiaran, Begoña Indakoetxea, Alazne Gabilondo, Mikel Tainta, Maria de Arriba, Ana Gorostidi, Miren Zulaica, Jorge Villanua, Zigor Diaz, Sergi Borrego-Ecija, Jaume Olives, Albert Lladó, Mircea Balasa, Anna Antonell, Nuria Bargallo, Enrico Premi, Maura Cosseddu, Stefano Gazzina, Alessandro Padovani, Roberto Gasparotti, Silvana Archetti, Sandra Black, Sara Mitchell, Ekaterina Rogaeva, Morris Freedman, Ron Keren, David Tang-Wai, Linn Öijerstedt, Christin Andersson, Vesna Jelic, Hakan Thonberg, Andrea Arighi, Chiara Fenoglio, Elio Scarpini, Giorgio Fumagalli, Thomas Cope, Carolyn Timberlake, Timothy Rittman, Christen Shoesmith, Robart Bartha, Rosa Rademakers, Carlo Wilke, Hans-Otto Karnath, Benjamin Bender, Rose Bruffaerts, Philip Vandamme, Mathieu Vandenbulcke, Catarina B. Ferreira, Gabriel Miltenberger, Carolina Maruta, Ana Verdelho, Sónia Afonso, Ricardo Taipa, Paola Caroppo, Giuseppe Di Fede, Giorgio Giaccone, Sara Prioni, Veronica Redaelli, Giacomina Rossi, Pietro Tiraboschi, Diana Duro, Maria Rosario Almeida, Miguel Castelo-Branco, Maria João Leitão, Miguel Tabuas-Pereira, Beatriz Santiago, Serge Gauthier, Sonja Schonecker, Elisa Semler, Sarah Anderl-Straub, Luisa Benussi, Giuliano Binetti, Roberta Ghidoni, Michela Pievani, Gemma Lombardi, Benedetta Nacmias, Camilla Ferrari, Valentina Bessi
Publikováno v:
The lancet / Neurology 18(12), 1103-1111 (2019). doi:10.1016/S1474-4422(19)30354-0
The Lancet Neurology, 18(12), 1103-1111. ELSEVIER SCIENCE INC
The Lancet Neurology, Vol. 18, No 12 (2019) pp. 1103-1111
van der Ende, E L, Meeter, L H, Poos, J M, Panman, J L, Jiskoot, L C, Dopper, E G P, Papma, J M, de Jong, F J, Verberk, I M W, Teunissen, C, Rizopoulos, D, Heller, C, Convery, R S, Moore, K M, Bocchetta, M, Neason, M, Cash, D M, Borroni, B, Galimberti, D, Sanchez-Valle, R, Laforce, R, Moreno, F, Synofzik, M, Graff, C, Masellis, M, Carmela Tartaglia, M, Rowe, J B, Vandenberghe, R, Finger, E, Tagliavini, F, de Mendonça, A, Santana, I, Butler, C, Ducharme, S, Gerhard, A, Danek, A, Levin, J, Otto, M, Frisoni, G B, Cappa, S, Pijnenburg, Y A L, Rohrer, J D, van Swieten, J C & GENetic Frontotemporal dementia Initiative (GENFI) 2019, ' Serum neurofilament light chain in genetic frontotemporal dementia : a longitudinal, multicentre cohort study ', Lancet Neurology, vol. 18, no. 12, pp. 1103-1111 . https://doi.org/10.1016/S1474-4422(19)30354-0
Lancet Neurology, 18(12), 1103-1111. Lancet Publishing Group
The Lancet Neurology, 18(12), 1103-1111. ELSEVIER SCIENCE INC
The Lancet Neurology, Vol. 18, No 12 (2019) pp. 1103-1111
van der Ende, E L, Meeter, L H, Poos, J M, Panman, J L, Jiskoot, L C, Dopper, E G P, Papma, J M, de Jong, F J, Verberk, I M W, Teunissen, C, Rizopoulos, D, Heller, C, Convery, R S, Moore, K M, Bocchetta, M, Neason, M, Cash, D M, Borroni, B, Galimberti, D, Sanchez-Valle, R, Laforce, R, Moreno, F, Synofzik, M, Graff, C, Masellis, M, Carmela Tartaglia, M, Rowe, J B, Vandenberghe, R, Finger, E, Tagliavini, F, de Mendonça, A, Santana, I, Butler, C, Ducharme, S, Gerhard, A, Danek, A, Levin, J, Otto, M, Frisoni, G B, Cappa, S, Pijnenburg, Y A L, Rohrer, J D, van Swieten, J C & GENetic Frontotemporal dementia Initiative (GENFI) 2019, ' Serum neurofilament light chain in genetic frontotemporal dementia : a longitudinal, multicentre cohort study ', Lancet Neurology, vol. 18, no. 12, pp. 1103-1111 . https://doi.org/10.1016/S1474-4422(19)30354-0
Lancet Neurology, 18(12), 1103-1111. Lancet Publishing Group
BACKGROUND: Neurofilament light chain (NfL) is a promising blood biomarker in genetic frontotemporal dementia, with elevated concentrations in symptomatic carriers of mutations in GRN, C9orf72, and MAPT. A better understanding of NfL dynamics is esse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4152ad8ad16d91438040d45c33447d2
https://pub.dzne.de/record/141625
https://pub.dzne.de/record/141625
Autor:
Janne M, Papma, Lize C, Jiskoot, Jessica L, Panman, Elise G, Dopper, Tom, den Heijer, Laura, Donker Kaat, Yolande A L, Pijnenburg, Lieke H, Meeter, Rick, van Minkelen, Serge A R B, Rombouts, John C, van Swieten
Publikováno v:
Neurology. 89(12)
To investigate cognitive function, gray matter volume, and white matter integrity in the presymptomatic stage of chromosome 9 open reading frame 72 repeat expansion (PresymptomaticOur data demonstrate lower scores on letter fluency, Stroop card I, an